Neuroone Medical Technologies is trading 7.1% down at $1.05 in pre-market; no company-specific announcement dated October 7, 2026, was identified in sources searched. - October 5 preliminary results: Q4 revenue was approximately $3.8 million, up 38.4%; full-year revenue was approximately $10.5 million, the top of guidance. - The company reported a record $4.5 million purchase order and $5.4 million in open orders; these results do not establish the decline’s cause. - Complete annual results are expected in December.